Literature DB >> 11117580

Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy.

R P Hall1, A D Smith, R D Streilein.   

Abstract

Dermatitis herpetiformis (DH) and isolated gluten-sensitive enteropathy (GSE) are gluten-sensitive diseases in which ingestion of dietary gluten results in the development of clinical disease. Patients with DH develop cutaneous IgA deposits and a severe skin disease, but rarely develop gastrointestinal symptoms. Patients with isolated GSE develop clinically significant gastrointestinal symptoms, but not skin disease or cutaneous IgA deposits. The aim of this study was to investigate the mechanism by which a mucosal immune response to the same dietary antigen can result in two distinct clinical phenotypes. T-cell lines were derived from activated T-cells in the small bowel mucosa of five patients with DH and 14 patients with isolated GSE and analyzed for T-cell markers and cytokine production in vitro. T-cell lines from DH and isolated GSE patients produced IFN-gamma after stimulation (mean: DH = 2,619 pg/ml; isolated GSE = 1,993 pg/ml; NS). T-cell lines from patients with DH, however, produced significantly more IL-4 than the T-cell lines from patients with isolated GSE (IL-4: DH = 2,010 pg/ml; isolated GSE = 235 pg/ml; P < 0.05). Analysis of intracytoplasmic cytokine production by the T-cell lines showed that T-cell lines from patients with DH were CD4+ predominant, with a greater proportion of CD4+/IL4+ cells than CD4+/IFN-gamma+ cells. In contrast, isolated GSE T-cell lines were predominantly CD8+, with an equal proportion of IL-4- and IFN-gamma-positive cells. These studies demonstrate that T cell lines from patients with DH produce significantly more IL-4 than T-cell lines from patients with isolated GSE, while producing similar amounts of IFN-gamma. This difference in cytokine pattern may play an important role in the different clinical manifestations of these two forms of gluten sensitivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11117580     DOI: 10.1023/a:1005512513007

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

Review 1.  Oral tolerance for the treatment of autoimmune diseases.

Authors:  H L Weiner
Journal:  Annu Rev Med       Date:  1997       Impact factor: 13.739

2.  Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease.

Authors:  C G Beckett; D Dell'Olio; M Kontakou; R T Przemioslo; S Rosen-Bronson; P J Ciclitira
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

3.  Increased proinflammatory cytokine gene expression in the colonic mucosa of coeliac disease patients in the early period after gluten challenge.

Authors:  Y Chowers; M N Marsh; L De Grandpre; A Nyberg; A N Theofilopoulos; M F Kagnoff
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

4.  The small intestinal mucosa in dermatitis herpetiformis. I. Severity and distribution of the small intestinal lesion and associated malabsorption.

Authors:  J R Brow; F Parker; W M Weinstein; C E Rubin
Journal:  Gastroenterology       Date:  1971-03       Impact factor: 22.682

5.  Detection of intracellular cytokines by flow cytometry.

Authors:  T Jung; U Schauer; C Heusser; C Neumann; C Rieger
Journal:  J Immunol Methods       Date:  1993-02-26       Impact factor: 2.303

6.  IL-4 directly modulates function of a model human intestinal epithelium.

Authors:  S P Colgan; M B Resnick; C A Parkos; C Delp-Archer; D McGuirk; A E Bacarra; P F Weller; J L Madara
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

7.  Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium.

Authors:  T S Halstensen; P Brandtzaeg
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

8.  T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma.

Authors:  N Krug; J Madden; A E Redington; P Lackie; R Djukanovic; U Schauer; S T Holgate; A J Frew; P H Howarth
Journal:  Am J Respir Cell Mol Biol       Date:  1996-04       Impact factor: 6.914

9.  Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.

Authors:  M Kontakou; R T Przemioslo; R P Sturgess; G A Limb; H J Ellis; P Day; P J Ciclitira
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

10.  Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type.

Authors:  H Secrist; R H DeKruyff; D T Umetsu
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  2 in total

1.  Nasal septal perforation in a patient with subclinical celiac disease: a possible new association.

Authors:  A Medina-Banegas; F A Pastor-Quirante; J Osete-Albaladejo; E López-Meseguer; F López-Andreu
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-10-22       Impact factor: 2.503

2.  Serum cytokine pattern in young children with screening detected coeliac disease.

Authors:  S Björck; S R Lindehammer; M Fex; D Agardh
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.